Featured Conference
     4th Annual Conference on Off-Label Usage
  Legal Scrutiny, Reimbursement and Legitimate Practices
  September 26 – 27, 2005 *   Park Hyatt Hotel, Philadelphia, PA 
Visit the conference website for more information and to register.
Why Attend This Conference:
- Distinguish lawful off-label communication from illegal off-label promotion
 - Hear updates from key enforcers on the latest off-label cases, including whistleblower, unfair competition, and false advertising.
 - Identify helpful ways to reduce your companys legal exposure
 - Hear the latest on reimbursement issues for off-label uses including Medicare Part D
 - Discover how- and when- to turn off-label data into on-label information
 - Investigate clinical trials disclosure and off-label dissemination
 
Conference Highlights:
- Featured presentations by the Director of FDA CDRH Office of Compliance, the US Attorneys Office, the Chief of Healthcare and Fraud Unit, and more!
 - Parallel tracks on Medical Devices and Pharmaceutical Industry explore all relevant concerns
 - Exclusive Post Conference Workshop:
CME and the OIG –
Continuing Medical Education and Off-Label Issues: Complying with the Office of the Inspector Generals New Guidelines 
Hear from Our Distinguished Faculty:
  Peggy Berry, ASTRAZENECA
 Timothy Ulatowski, FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
 Monica Schultz, REGULATORY AND CLINICAL RESEARCH INSTITUTE 
 Dr. Steven Brotman, WYETH PHARMACEUTICALS
 Kevin “Kip” Piper, HEALTH RESULTS GROUP LLC
  Michael Loucks, FIRST ASSISTANT U.S. ATTORNEY, DISTRICT OF MASSACHUSETTS
 Susan Winkler, CHIEF OF HEALTH CARE FRAUD UNIT US ATTORNEYS OFFICE, BOSTON, MASSACHUSETTS
 Viveca Parker, US ATTORNEYS OFFICE, EASTERN DISTRICT OF PENNSYLVANIA
 Daniel Kracov, PATTON BOGGS LLP
 Laurence Freedman, PATTON BOGGS LLP
  Erika Kelton, PHILLIPS & COHEN LLP
 Thomas Muldoon TAKEDA PHARMACEUTICAL
 Mark McAndrew, WILEY, REIN&FIELDING LLP
 Mark Schaffer, THOMSON HEALTHCARE 
  Maureen Doyle-Scharff, ABBOTT LABS, ROSS PRODUCTS DIVISION
What attendees have said about past Off-Label Usage Conferences:
“A variety of perspectives offered in a complete, informative, detailed program.”
“The speakers kept the audience enthralled with details of specific legal cases as seen from opposing perspectives.”
“Good discussions and a lot of well presented, new information.”
For more information and to register, please visit the website.
            
		

![6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]](http://ec2-54-175-84-28.compute-1.amazonaws.com/pharma-mkting.com/wp-content/uploads/2021/04/6DigitalTools_600px-100x70.jpg)




